Pro‑coagulant Considerations in Patients with Arterial Hypertension and Multifocal Atherosclerosis
Open Access
- 11 July 2024
- journal article
- research article
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 23 (3) , 36-45
Abstract
The aim of the work to determine the features of hemostasis and blood rheology in patients with arterial hypertension (HTN) and multifocal atherosclerosis (MFA).Materials and methods. The study enrolled male and female patients aged from 40 to 70 years, including 59 patients with controlled stage I–II hypertension and multifocal vascular lesions (Group 1) and 42 patients with controlled stage III hypertension, who have suffered an ischemic stroke and have multifocal vascular lesions (Group 2). A test using the Thrombodynamics analyser system T-2 (GemaKor, LLC, Moscow, Russia) was performed to detect the impairment of hemostasis.Results. Patients with HTN and MFA have an impaired coagulation hemostasis system (an increase in the initial and stationary clot growth rate and the size of the clot, as well as the presence of spontaneous clots), which leads to a high residual risk of cerebral complications, despite BP lowering to target figures and control of lipid profile.Discussion. Elevated blood pressure in patients with MFA leads to endothelial dysfunction, which is accompanied by activation of coagulation and fibrinolysis pathways. These changes lead to a violation of microcirculatory hemostasis in the brain, the development and progression of cerebral ischemia, and subsequently the occurrence of stroke, both the first and repeated.Conclusion. An important result of this study is the first registered change in the coagulation link of hemostasis in patients with HTN and MFA aged from 40 to 70 years, which can be considered an additional criterion for stroke prediction.Keywords
This publication has 30 references indexed in Scilit:
- Usefulness of Carotid Ultrasound Screening in Primary Cardiovascular Prevention: A Systematic ReviewCurrent Problems in Cardiology, 2023
- Inflammation and hypertension: Underlying mechanisms and emerging understandingsJournal of Cellular Physiology, 2023
- Treatment of HypertensionJAMA, 2022
- Microvascular rarefaction in patients with cerebrovascular eventsMicrovascular Research, 2022
- Whole blood viscosity is associated with baseline cerebral perfusion in acute ischemic strokeNeurological Sciences, 2021
- Antiplatelet Therapy for Secondary Prevention of Vascular Disease ComplicationsCurrent Atherosclerosis Reports, 2017
- Incorrect Values and Excluded Units of Measure.JAMA, 2017
- Mechanism and Clinical Significance of the Prothrombotic State in Patients With Essential HypertensionClinical Cardiology, 2010
- International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With AtherothrombosisJAMA, 2006
- High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunctionAmerican Journal of Hypertension, 2005